{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05780684",
            "orgStudyIdInfo": {
                "id": "STUDY02001873"
            },
            "secondaryIdInfos": [
                {
                    "id": "22BRO873",
                    "type": "OTHER",
                    "domain": "Dartmouth Health"
                }
            ],
            "organization": {
                "fullName": "Dartmouth-Hitchcock Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer",
            "officialTitle": "Adaptive, Individualized Dose Escalation of Fluorouracil-Based Chemotherapy for Gastrointestinal Cancer: Pilot Study of the FOX Regimen",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "individualized-dose-escalation-of-fu-for-gastrointestinal-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-07-14",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-05",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-10",
            "studyFirstSubmitQcDate": "2023-03-10",
            "studyFirstPostDateStruct": {
                "date": "2023-03-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-07-14",
            "lastUpdatePostDateStruct": {
                "date": "2023-07-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Gabriel A. Brooks",
                "investigatorTitle": "Associate Professor of Medicine",
                "investigatorAffiliation": "Dartmouth-Hitchcock Medical Center"
            },
            "leadSponsor": {
                "name": "Dartmouth-Hitchcock Medical Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "This is a single-arm clinical trial that will evaluate the feasibility of a chemotherapy regimen adaptive, individualized dose escalation of 5-FU chemotherapy for patients who have good tolerance of the initial dose. Study participants will also receive oxaliplatin chemotherapy together with 5-FU, at standard doses. The goal of the study is to examine the feasibility and effectiveness of this approach, using individualized dose escalation of 5-FU in patients who do not have serious side effects at lower doses."
        },
        "conditionsModule": {
            "conditions": [
                "Colorectal Cancer",
                "Esophagus Cancer",
                "Appendix Cancer",
                "Small Bowel Cancer",
                "Ampullary Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 36,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Study Arm",
                    "type": "EXPERIMENTAL",
                    "description": "All patients in this single-study arm will be exposed to the FOX regimen, an adaptively dose-escalated chemotherapy regimen. The FOX regimen is comprised of oxaliplatin 85 mg/m2 IV on Day 1; leucovorin calcium 350 mg IV on Day 1; and infusional 5-FU IV over 46 hours (Days 1 and 2) - starting at a dose of 2,400 mg/m2 and adaptively adjusted toward a maximum dose of 3,200 mg/m2 over Cycles 2-4 using a clinical algorithm.",
                    "interventionNames": [
                        "Other: FOX dose-escalation algorithm"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "FOX dose-escalation algorithm",
                    "description": "Chemotherapy dose-escalation algorithm based on the FOLFOX and FOLFOXIRI regimens",
                    "armGroupLabels": [
                        "Study Arm"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Proportion of patients that receive dose intensified infusional 5-FU in Cycle 6 of the FOX regimen",
                    "description": "The proportion of patients who receive dose-intensified infusional 5-FU (dosed at greater than or equal to 2,800 mg/m2) in Cycle 6 of the FOX regimen.",
                    "timeFrame": "Through day 1 of Cycle 6 of FOX regimen (cycle length is 14 days)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Response rate to chemotherapy",
                    "description": "Response rate (stratified by colorectal cancer vs. gastroesophageal cancer) as defined using RECIST 1.1 imaging criteria",
                    "timeFrame": "Through 6 months from Cycle 1 Day 1 of FOX regimen"
                },
                {
                    "measure": "Progression-free survival",
                    "description": "Progression-free survival (PFS, stratified by colorectal cancer vs. gastroesophageal cancer, determined by retrospective review of medical records)",
                    "timeFrame": "Through 12 months from Cycle 1 Day 1 of FOX regimen"
                },
                {
                    "measure": "Dose intensity of 5-FU and oxaliplatin",
                    "description": "Dose intensity of 5-FU and oxaliplatin over Cycles 1-6. Dose intensity will be calculated separately for each component of the FOLFOX regimen (5-FU infusion and oxaliplatin).",
                    "timeFrame": "Through day 1 of Cycle 6 of FOX regimen (cycle length is 14 days)"
                },
                {
                    "measure": "Mean plasma uracil concentration",
                    "description": "Difference in mean plasma uracil concentration between patients who did and did not achieve sustained 5-FU dose escalation to \u2265 2,800 mg/m2 (primary endpoint)",
                    "timeFrame": "Single treatment visit 0-30 days before Day 1 of Cycle 1 of FOX regimen, (cycle length is 14 days)"
                },
                {
                    "measure": "5-FU drug exposure",
                    "description": "5-FU drug exposure, measured as the area under the drug concentration curve (AUC). AUC will be calculated by multiplying the measured 5-FU concentration at steady state by the 5-FU infusion duration in hours.",
                    "timeFrame": "Single treatment visit on Day 3 of treament Cycle 5 or Cycle 6 of FOX regimen, (cycle length is 14 days)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 18 years\n* Diagnosis of metastatic or locally advanced/inoperable colorectal cancer or non-colorectal gastrointestinal cancer (including cancers of the stomach, esophagus, appendix, small bowel, and ampulla)\n* Clinically appropriate staging imaging of the chest, abdomen, and pelvis performed within 30 days prior to registration\n* ECOG Performance Status: 0-1\n\nExclusion Criteria:\n\n* Any prior receipt of oxaliplatin or fluoropyrimidine chemotherapy (other than radiation-sensitizing fluoropyrimidine chemotherapy)\n* Prior receipt of systemic chemotherapy in the 6 months prior to Day 1 of Cycle 1 of FOX (other than radiation-sensitizing chemotherapy)\n* Known mismatch repair deficiency or microsatellite instability-high disease\n* Known dihydropyrimidine dehydrogenase (DPD) deficiency, as identified by clinically indicated screening\n* Any confirmed second malignancy that is likely to require systemic therapy during the course of the six-month study period, in the opinion of the enrolling investigator\n* Any of the following baseline laboratory abnormalities:\n\n  * Absolute neutrophil count (ANC) \\< 2,500/mm3\n  * Platelet count \\< 100,000/mm3\n  * Hemoglobin \\< 9 g/dL\n  * Creatinine \\> 1.5 x ULN\n  * Total bilirubin \\> 1.5 x ULN\n  * AST/ALT \\> 5 x ULN\n  * Patients who are unable to provide informed consent\n  * Patients who are pregnant or breastfeeding\n  * Patients who are incarcerated, homeless, or have active substance use disorders",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Casey O'Quinn, M.S.",
                    "role": "CONTACT",
                    "phone": "603-653-9338",
                    "email": "Casey.M.O'Quinn@hitchcock.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Gabriel A Brooks, M.D.",
                    "affiliation": "Dartmouth-Hitchcock Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Dartmouth-Hitchcock Medical Center",
                    "status": "RECRUITING",
                    "city": "Lebanon",
                    "state": "New Hampshire",
                    "zip": "03756",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gabriel A Brooks, MD",
                            "role": "CONTACT",
                            "phone": "603-650-9474",
                            "email": "gabriel.a.brooks@hitchcock.org"
                        },
                        {
                            "name": "Gabriel A Brooks, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.64229,
                        "lon": -72.25176
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004938",
                    "term": "Esophageal Neoplasms"
                },
                {
                    "id": "D000001063",
                    "term": "Appendiceal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007414",
                    "term": "Intestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                },
                {
                    "id": "D000004935",
                    "term": "Esophageal Diseases"
                },
                {
                    "id": "D000002430",
                    "term": "Cecal Neoplasms"
                },
                {
                    "id": "D000002429",
                    "term": "Cecal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "asFound": "Gastrointestinal Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8088",
                    "name": "Esophageal Neoplasms",
                    "asFound": "Esophagus Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4375",
                    "name": "Appendiceal Neoplasms",
                    "asFound": "Appendix Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10448",
                    "name": "Intestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8085",
                    "name": "Esophageal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5680",
                    "name": "Cecal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5679",
                    "name": "Cecal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2141",
                    "name": "Esophageal Cancer",
                    "asFound": "Esophagus Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5273",
                    "name": "Small Intestine Cancer",
                    "asFound": "Small Bowel Cancer",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M1674",
                    "name": "Oxaliplatin",
                    "relevance": "LOW"
                },
                {
                    "id": "M8600",
                    "name": "Fluorouracil",
                    "relevance": "LOW"
                },
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                },
                {
                    "id": "M6191",
                    "name": "Leucovorin",
                    "relevance": "LOW"
                },
                {
                    "id": "M29233",
                    "name": "Levoleucovorin",
                    "relevance": "LOW"
                },
                {
                    "id": "T447",
                    "name": "Folinic Acid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}